| 摘要 |
The present invention relates to a method for preventing or controlling pathological changes which occur in association with cataract formation in the mammalian eye by reducing the amount of or inhibiting the action of transforming growth factor-beta(TGFbeta). The invention also relates to the use of inhibitors of TGFbeta to prevent or minimise "aftercataract". |
